Quisinostat dihydrochloride (Synonyms: JNJ-26481585 dihydrochloride) |
Catalog No.GC19936 |
El diclorhidrato de quisinostat (diclorhidrato de JNJ-26481585) es un potente inhibidor pan-HDAC disponible por vÍa oral con IC50 de 0,11 nM, 0,33 nM, 0,64 nM, 0,46 nM y 0,37 nM para HDAC1, HDAC2, HDAC4, HDAC10 y HDAC11, respectivamente. El diclorhidrato de quisinostat tiene una actividad antitumoral de amplio espectro.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 875320-31-3
Sample solution is provided at 25 µL, 10mM.
Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity[1].
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *